Clinical Trial Update: An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed Conditions [Phase 1]

View source ↗

Summary

Phase 1 open-label crossover trial assessing pharmacokinetics and bioequivalence of dapagliflozin plus metformin vs separate co-administration in healthy volunt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Dapagliflozin/metformin (dapagliflozin/metformin)
• Forxiga (dapagliflozin)
• Glucophage® Long, ER Tablets (metformin XR)
• metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2018-02-19